A
NeuroThaw A
Entry-level design with left-ear tVNS, standalone operation, a 0.96-inch OLED, physical buttons, and six program slots.
EAR-BASED tVNS PLATFORM · IN DEVELOPMENT
A focused platform for autonomic wellness.
NeuroThaw is developing a non-invasive, ear-based transcutaneous vagus nerve stimulation platform with two product configurations: NeuroThaw A and NeuroThaw B.
In development · No certification, availability, pricing, or launch date has been announced
CONCEPT VISUALIZATION · NOT A PRODUCT PHOTOGRAPH
NTConceptA / B
01 A visual representation of the platform concept. Final product appearance has not been published.
DEVELOPMENT FOCUS
Clear architecture. Clear boundaries.
Both configurations are designed for standalone operation. NeuroThaw B adds right-ear PPG and app information synchronization without giving the app control over stimulation.
Gut health is the first intended application area in the current product plan. This direction does not establish clinical efficacy or a disease-related claim.
B
NeuroThaw B
Advanced design with left-ear tVNS, right-ear PPG, a 3.5-inch LCD, app information sync, and nine program slots.
↗
Evidence boundaries
Design requirements do not establish completed verification, clinical efficacy, proven safety, certification, or market authorization.
THE PLATFORM
Two configurations.
One standalone foundation.
NeuroThaw A is the entry-level configuration. NeuroThaw B adds right-ear PPG monitoring and app information synchronization.
Compare every confirmed feature →tVNS
PPG
DEVICE
NT
DESIGN ARCHITECTURE
Core operation stays with the device.
The current platform design separates user-interface functions from stimulation safety-control functions. Current, voltage, and impedance monitoring are design requirements and are not claims of completed verification.
- Standalone device operation
- Monitoring included as a design requirement
- B app synchronization does not control stimulation
PRODUCT STATUS
Both configurations are in development.
Final use instructions, stimulation parameters, safety information, certifications, market availability, pricing, and launch dates have not been announced.
Review the platform ↗NEUROTHAW